The impact scores are informative. The strengths are strongly positive (+7.5 to +8.6), and the weaknesses are mostly moderate (-2.3 to -4.3) except the "longer training" underspecification (-8.8) which the model correctly flags as impactful despite being labeled "Minor" — that's a genuine reproducibility gap for the paper's best results. The overall balance still strongly supports acceptance given real contributions.

Here is my final review:

---

## Summary

TWINFLOW proposes a framework for training 1-step generative models that eliminates the need for auxiliary networks (GAN discriminators, frozen teacher models, or separate score functions). The core idea is to extend the flow-matching time domain to [-1, 1], creating "twin trajectories" (positive for real data, negative for model-generated fake data), and minimize the velocity-field difference between them. The method is evaluated on text-to-image generation at multiple scales, including full-parameter training on Qwen-Image-20B, and achieves strong GenEval scores (0.83 on SANA-0.6B, 0.89 on Qwen-Image-20B with longer training) with just 1-2 NFEs.

## Strengths

- **Concrete memory-efficiency advantage (Fig. 2b, Tab. 3):** DMD2 and SANA-Sprint run OOM (>80GB) on Qwen-Image-20B at batch size 1, while TWINFLOW fits batch size 24 in 76GB. This directly supports the central claim of eliminating memory overhead from auxiliary networks and addresses a real barrier to scaling few-step methods to large models.

- **Full-parameter 20B training results (Tab. 3):** The "longer training" variant achieves GenEval 0.89 (1-NFE) and 0.90 (2-NFE), matching/exceeding the original Qwen-Image's 100-NFE score of 0.87. Comparisons against VSD, DMD*, SiD*, sCM, MeanFlow, and RCGM on the same backbone show clear wins across all three metrics (GenEval, DPG-Bench, WISE).

- **Strong 1-NFE GenEval results on SANA backbones (Tab. 4):** TWINFLOW-0.6B achieves GenEval 0.83 at 1-NFE, surpassing SANA-Sprint-0.6B (0.72), RCGM-0.6B (0.80), and all other 1-NFE methods listed, using the same backbone architectures.

## Weaknesses

### Fatal
None.

### Major
- **The RCGM collapse on Qwen-Image at 1-NFE is unexplained.** In Tab. 2, Qwen-Image-RCGM at 1-NFE scores GenEval 0.52 and DPG 59.50 — dramatically lower than RCGM at 1-NFE on other backbones (OpenUni: 0.80, SANA-0.6B: 0.80) and lower than Qwen-Image-RCGM at 2-NFE (0.82). The ablation in Fig. 4b confirms the "w/o L_TwinFlow" condition is this RCGM baseline, making the 27-point DPG improvement from adding L_TwinFlow dramatic but unexplained. Without discussion of why RCGM fails specifically in this setting, readers cannot determine whether the comparison is fair or whether TWINFLOW's large margin is partly an artifact of a confounded baseline.

### Minor
- **The abstract's "outperforming SANA-Sprint" claim is unqualified.** On SANA-1.6B at 1-NFE, TWINFLOW wins on GenEval (0.81 vs. 0.76) but trails on DPG-Bench (79.1 vs. 80.1). The DPG gap is acknowledged only in Section 4.3 and attributed to SANA-Sprint's proprietary training data — a plausible but unverified explanation. The headline should be more precise about which metric is being compared.

- **The "self-adversarial" framing is imprecise.** The title, abstract, and Section 3.1 use "self-adversarial" throughout, but the method involves no min-max optimization, no discriminator, and no competing objectives. It minimizes velocity-field differences between twin trajectories, which is closer to self-consistency or self-distillation. The mathematics is sound but the terminology may mislead readers about the nature of the contribution.

- **The "longer training" variant in Tab. 3 (GenEval 0.89/0.90) is underspecified.** No details are given about training duration, step count, learning rate schedule, or whether the same L_TwinFlow loss continues. This makes the paper's strongest results irreproducible and should be clarified.

- **TWINFLOW-1.6B scores lower than TWINFLOW-0.6B on GenEval (0.81 vs. 0.83 at 1-NFE, Tab. 4).** This is the opposite of what scaling would predict, and the paper does not comment on or explain this inversion.

### Trivial
- Fig. 4c caption describes color values in the range 0.70–0.85 as "NFE values" when the y-axis already shows NFE (1–5); the color bar appears to represent GenEval scores. The labeling should be clarified.

## Nice-to-Haves
- Explain why RCGM at 1-NFE collapses on Qwen-Image but not on SANA or OpenUni.
- Report variance or multiple-seed results for comparisons with small margins (e.g., TWINFLOW-0.6B vs RCGM-0.6B: 0.83 vs 0.80 on GenEval).
- Clarify whether the memory advantage in Fig. 2b (measured with LoRA tuning) holds similarly under full-parameter training.

## Removed Points
These points are flagged to be removed; treat them with caution.
- **"Consistency methods contradiction"** — The critic claimed the paper's statement about consistency methods degrading at <4 NFE is contradicted by RCGM's 0.80 GenEval on SANA-0.6B. But the paper says "often," not "always," and RCGM on Qwen-Image at 1-NFE (0.52) supports the claim. This is a misreading.
- **"Missing dataset details"** — The paper references App. C for training settings, which the parser stripped. The speculation about proprietary data being unverifiable is a reviewer-knowledge issue, not an author error.
- **"Conflicting demands analysis"** — The paper acknowledges the conflict and provides a λ ablation. Requesting deeper analysis is a nice-to-have, not a weakness.
- **"Statistical significance"** — Single-run evaluation with standard benchmarks is the norm for large-scale text-to-image; not an omission.

## Novel Insights
None beyond the paper's own contributions.

## Suggestions
- Specify the training steps, schedule, and loss configuration for the "longer training" condition.
- Add a note in the abstract or contributions clarifying that the comparison with SANA-Sprint is on GenEval, with DPG-Bench results discussed in Section 4.3.
- Discuss the counterintuitive 0.6B > 1.6B GenEval inversion.
- Provide an explanation or hypothesis for the Qwen-Image-RCGM collapse at 1-NFE.

MY FINAL SCORE: <score>8</score>
MY FINAL DECISION: <decision>Accept</decision>